CD38 and Miyoshi myopathy: (High BLM expression was also associated with a poor outcome in a cohort of MM patients at relapse treated by anti-CD38 MoAb (78) (Figure 2D) at diagnosis non eligible to HDT and ASCT (n=63) (Figure 2E).